Olumiant

Olumiant (baricitinib) is a prescription medication used to treat moderate to severe rheumatoid arthritis, an autoimmune condition where the immune system attacks joints. It works by inhibiting certain enzymes (JAK1 and JAK2) that are part of the body's inflammatory process, thereby reducing joint pain and swelling. In 2021, it also received emergency approval for treating certain cases of COVID-19, as it can help lessen inflammation caused by the virus. Olumiant is taken orally as a tablet and is typically prescribed alongside other medications, with close medical supervision to manage potential side effects.